Cell Cycle Analysis Market Research Report – Forecast to 2023

Cell Cycle Analysis Market Research Report – Forecast to 2023

ID: MRFR/HC/0202-HCRR | October, 2018 | Region: Global | 85 pages | Half-Cooked Research Reports

Cell Cycle Analysis Market: Information by Product (Consumables, Instruments, & Others), Application (Cell Identification and Others), End-User (Academics & Research Institutions, Hospitals & Diagnostic Laboratories, & Others) – Global Forecast Till 2023


Market Scenario


The cell cycle analysis market is expected to show a prominent growth during the forecast period (2018–2023).


Cell cycle analysis products are used in numerous life science research activities as well as in biomedical research and clinical research laboratories. Cell cycle analysis is carried out to check the effects of various internal and external factors on cells. Increasing expenditure on cell level research by the corporate sector, government initiatives for cell research, increasing chronic genetic diseases, rising occurrence of cell-specific diseases, and cancer and aggressive strategies by market players are expected to drive the growth of the market. For instance, In March 2018, Agilent technologies which is one of the major players in the cell cycle analysis market acquired advanced analytical technologies for USD 250 million.


The high costs of cell analysis instruments and expensive maintenance might be a problem for small research groups and it can hamper the growth of the market during the assessment period.


Segmentation


The cell cycle analysis market has been segmented on the basis of product, application, and end-user.


On the basis of product, the market has been classified as consumables and instruments. The consumables segment has been further divided into reagents, assay kits, microplates, and other consumables. The assay kits segment has been further divided into immunoassay and cell-based assay. The instruments segment has been classified into microscopes, flow cytometry, spectrophotometer, qPCR, cell counter, high content screening systems, and cell microarrays. The microscopes segment has been divided into electron microscopes, inverted microscopes, stereomicroscopes, fluorescence and confocal microscopes, phase contrast microscopes, Near-Field Scanning Optical Microscopes (NSOM), and other microscopes. The flow cytometers sub-segment has been segmented into flow cytometry instruments and flow cytometry software. The spectrophotometers segment has been divided into fluorescence microplate readers, microplate spectrophotometers, and colorimeters. Furthermore, cell counters have been sub-segmented into automated cell counters and hemocytometers and manual cell counters. The synthetic High-Content Screening (HCS) systems segment includes cell imaging and analysis HCS systems and HCS software.


The market, by application, has been segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting and quality control, cell interaction, cell structure study, target identification, and validation and single-cell analysis.


Based on end-user, the market has been divided into, academics and research institutions, hospitals and diagnostic laboratories, pharmaceuticals (CROs and biotechnology companies), and other end-users.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The cell cycle analysis market in the Americas has further been segmented into North America and South America, with the North American market is divided into the US and Canada.


The European cell cycle analysis market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The cell cycle analysis market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cell cycle analysis market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Cell Cycle Analysis Market Share, by Region, 2017 (%)


Cell Cycle Analysis Market Share


Source: MRFR Analysis


The Americas are likely to dominate the cell cycle analysis market owing to the presence of well-established research and development facilities, government funding to encourage cell level research and development, and rising prevalence of cancer. According to the National Cancer Institute, in 2016, 15.5 million cancer cases were found in the US. The expenditure on cancer care in 2017 was USD 147.3 billion.


The European market is expected to be the second-largest cell cycle analysis market. The market growth in this region can be attributed to the adoption of highly advanced technology. Moreover, a growing number of life sciences and medical research institutes in Europe is contributing to the growth of the market in this region.


Asia-Pacific is expected to be the fastest-growing cell cycle analysis market during the forecast period owing to the rising investments in life science and healthcare research and government support and favorable policies for the research sector.


The market in the Middle East and Africa is expected to account for the smallest share of the cell cycle analysis market due to an underdeveloped research sector, lack of technical knowledge, and poor research and development facilities.


Company Profiles    



  • Becton, Dickinson and Company

  • Merck & Co., Inc.

  • Thermo Fisher Scientific, Inc.

  • Danaher Corporation

  • GE Healthcare

  • Agilent Technologies, Inc.

  • Olympus Corporation

  • PerkinElmer, Inc.

  • Promega Corporation

  • Bio-Rad Laboratories, Inc.

  • Miltenyi Biotech

  • Nexcelom Bioscience LLC.


Cell Cycle Analysis Market, by Product



  • Consumables




    • Reagents

    • Assay Kits


      • Immunoassays

      • Cell-Based Assays


    • Microplates

    • Other Consumables




  • Instruments




    • Microscopes


      • Electron Microscopes

      • Inverted Microscopes

      • Stereomicroscopes

      • Fluorescence and Confocal Microscopes

      • Phase Contrast Microscopes

      • Near-field Scanning Optical Microscopes (NSOM)

      • Other Microscopes


    • Flow Cytometers


      • Flow Cytometry Instruments

      • Flow Cytometry Software


    • Spectrophotometers


      • Fluorescence Microplate Readers

      • Microplate Spectrophotometers

      • Colorimeters


    • qPCR

    • Cell Counters


      • Automated Cell Counters

      • Hemocytometers and Manual Cell Counters


    • High-content screening (HCS) Systems


      • Cell Imaging and Analysis HCS Systems

      • HCS Software


    • Cell Microarrays



Cell Cycle Analysis Market, by Application



  • Cell Identification

  • Cell Viability

  • Cell Signaling Pathway/Signal Transduction

  • Cell Proliferation

  • Cell Counting and Quality Control

  • Cell Interaction

  • Cell Structure Study

  • Target Identification and Validation

  • Single-Cell Analysis


Cell Cycle Analysis Market, by End-User



  • Academics & Research Institutions

  • Hospitals and Diagnostic Laboratories

  • Pharmaceuticals- CROs and Biotechnology Companies

  • Other End-Users


Cell Cycle Analysis Market, by Region



  • Americas

  • North America

  • US

  • Canada

  • South America

  • Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe

  • Asia-Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Middle East

  • Africa


Intended Audience



  • Cell cycle analysis instrument manufacturers

  • Cell cycle analysis consumables manufacturers

  • Cell cycle analysis product distributors and suppliers

  • Healthcare providers and diagnostic centers

  • Medical device manufacturers

  • Research institutes and academic centers

  • Contract Research Organizations (CROs)

  • Government associations

  • Market research and consulting

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Cell Cycle Analysis Market, by Product

6.1 Introduction

6.2 Consumables

6.2.1 Reagents

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2 Assay Kits

6.2.2.1 Immunoassays

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2.2 Cell-Based Assays

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



6.2.3 Microplates

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.4 Other Consumables

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Instruments

6.3.1 Microscopes

6.3.1.1 Electron Microscopes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.1.2 Inverted Microscopes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.1.3 Stereomicroscopes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.1.4 Fluorescence and Confocal Microscopes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.1.5 Phase Contrast Microscopes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.1.6 Near-field Scanning Optical Microscopes (NSOM)

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.1.7 Other Microscopes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



6.3.2 Flow Cytometers

6.3.2.1 Flow Cytometry Instruments

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.2.1 Flow Cytometry Software

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.3 Spectrophotometers

6.3.3.1 Fluorescence Microplate Readers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.3.2 Microplate Spectrophotometers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.3.3 Colorimeters

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.4 qPCR

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.5 Cell Counters

6.3.5.1 Automated Cell Counters

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.5.2 Hemocytometers and Manual Cell Counters

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.6 High-content screening (HCS) Systems

6.3.6.1 Cell Imaging and Analysis HCS Systems

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.6.2 HCS Software

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023





6.3.7 Cell Microarrays

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 7. Cell Cycle Analysis Market, by Application

7.1 Introduction

7.2 Cell Identification

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Cell Viability

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Cell Signaling Pathway/Signal Transduction

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.5 Cell Proliferation

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.6 Cell Counting and Quality Control

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



7.7 Cell Interaction

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.8 Cell Structure Study

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.9 Target Identification and Validation

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.10 Single-Cell Analysis

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 8. Cell Cycle Analysis Market, by End-User

8.1 Introduction

8.2 Academics & Research Institutions

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Hospitals and Diagnostic Laboratories

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Pharmaceutical- CROs and Biotechnology Companies

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.5 Other End-Users

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Cell Cycle Analysis Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Becton, Dickinson and Company

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Merck & Co., Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Thermo Fisher Scientific, Inc.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Danaher Corporation

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 GE Healthcare

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Agilent Technologies, Inc.

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Olympus Corporation

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 PerkinElmer, Inc.

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Promega Corporation

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Bio-Rad Laboratories, Inc.

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Miltenyi Biotech

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Nexcelom Bioscience LLC.

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Cell Cycle Analysis Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Cell Cycle Analysis Market Synopsis, 2018–2023

Table 2 Cell Cycle Analysis Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Cell Cycle Analysis Market, by Region, 2018–2023 (USD Million)

Table 4 Cell Cycle Analysis Market, by Product, 2018–2023 (USD Million)

Table 5 Cell Cycle Analysis Market, by Application, 2018–2023 (USD Million)

Table 6 Cell Cycle Analysis Market, by End-User, 2018–2023 (USD Million)

Table 7 North America: Cell Cycle Analysis Market, by Product, 2018–2023 (USD

Million)

Table 8 North America: Cell Cycle Analysis Market, by Application, 2018–2023 (USD

Million)

Table 9 North America: Cell Cycle Analysis Market, by, End-User 2018–2023 (USD

Million)

Table 10 US: Cell Cycle Analysis Market, by Product, 2018–2023 (USD Million)

Table 11 US: Cell Cycle Analysis Market, by Application, 2018–2023 (USD Million)

Table 12 US: Cell Cycle Analysis Market, by, End-User 2018–2023 (USD Million)

Table 13 Canada: Cell Cycle Analysis Market, by Product, 2018–2023 (USD Million)

Table 14 Canada: Cell Cycle Analysis Market, by Application, 2018–2023 (USD Million)

Table 15 Canada: Cell Cycle Analysis Market, by, End-User 2018–2023 (USD

Million)

Table 16 South America: Cell Cycle Analysis Market, by Product, 2018–2023 (USD

Million)

Table 17 South America: Cell Cycle Analysis Market, by Application, 2018–2023 (USD

Million)

Table 18 South America: Cell Cycle Analysis Market, by, End-User 2018–2023 (USD

Million)

Table 19 Europe: Cell Cycle Analysis Market, by Product, 2018–2023 (USD Million)

Table 20 Europe: Cell Cycle Analysis Market, by Application, 2018–2023 (USD Million)

Table 21 Europe: Cell Cycle Analysis Market, by, End-User 2018–2023 (USD Million)

Table 22 Western Europe: Cell Cycle Analysis Market, by Product, 2018–2023 (USD

Million)

Table 23 Western Europe: Cell Cycle Analysis Market, by Application, 2018–2023 (USD

Million)

Table 24 Western Europe: Cell Cycle Analysis Market, by, End-User 2018–2023

(USD Million)

Table 25 Eastern Europe: Cell Cycle Analysis Market, by Product, 2018–2023 (USD

Million)

Table 26 Eastern Europe: Cell Cycle Analysis Market, by Application, 2018–2023 (USD

Million)

Table 27 Eastern Europe: Cell Cycle Analysis Market, by, End-User 2018–2023

(USD Million)

Table 28 Asia-Pacific: Cell Cycle Analysis Market, by Product, 2018–2023 (USD

Million)

Table 29 Asia-Pacific: Cell Cycle Analysis Market, by Application, 2018–2023 (USD

Million)

Table 30 Asia-Pacific: Cell Cycle Analysis Market, by, End-User 2018–2023 (USD

Million)

Table 31 Middle East & Africa: Cell Cycle Analysis Market, by Product, 2018–2023

(USD Million)

Table 32 Middle East & Africa: Cell Cycle Analysis Market, by Application, 2018–2023

(USD Million)

Table 33 Middle East & Africa: Cell Cycle Analysis Market, by, End-User 2018–2023

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Cell Cycle Analysis Market

Figure 3 Segmentation Market Dynamics for Cell Cycle Analysis Market

Figure 4 Cell Cycle Analysis Market Share, by Product, 2017

Figure 5 Cell Cycle Analysis Market Share, by Application, 2017

Figure 6 Cell Cycle Analysis Market Share, by, End-User 2017

Figure 7 Cell Cycle Analysis Market Share, by Region, 2017

Figure 8 North America: Cell Cycle Analysis Market Share, by Country, 2017

Figure 9 Europe: Cell Cycle Analysis Market Share, by Country, 2017

Figure 10 Asia-Pacific: Cell Cycle Analysis Market Share, by Country, 2017

Figure 11 Middle East & Africa: Cell Cycle Analysis Market Share, by Country, 2017

Figure 12 Cell Cycle Analysis Market: Company Share Analysis, 2017 (%)

Figure 13 Becton, Dickinson and Company: Key Financials

Figure 14 Becton, Dickinson and Company: Segmental Revenue

Figure 15 Becton, Dickinson and Company: Geographical Revenue

Figure 16 Merck & Co., Inc.: Key Financials

Figure 17 Merck & Co., Inc.: Segmental Revenue

Figure 18 Merck & Co., Inc.: Geographical Revenue

Figure 19 Thermo Fisher Scientific, Inc.: Key Financials

Figure 20 Thermo Fisher Scientific, Inc.: Segmental Revenue

Figure 21 Thermo Fisher Scientific, Inc.: Geographical Revenue

Figure 22 Danaher Corporation: Key Financials

Figure 23 Danaher Corporation: Segmental Revenue

Figure 24 Danaher Corporation: Geographical Revenue

Figure 25 GE Healthcare: Key Financials

Figure 26 GE Healthcare: Segmental Revenue

Figure 27 GE Healthcare. Geographical Revenue

Figure 28 Agilent Technologies, Inc.: Key Financials

Figure 29 Agilent Technologies, Inc.: Segmental Revenue

Figure 30 Agilent Technologies, Inc.: Geographical Revenue

Figure 31 Olympus Corporation: Key Financials

Figure 32 Olympus Corporation: Segmental Revenue

Figure 33 Olympus Corporation: Geographical Revenue

Figure 34 PerkinElmer, Inc.: Key Financials

Figure 35 PerkinElmer, Inc.: Segmental Revenue

Figure 36 PerkinElmer, Inc.: Geographical Revenue

Figure 37 Promega Corporation: Key Financials

Figure 38 Promega Corporation: Segmental Revenue

Figure 39 Promega Corporation: Geographical Revenue

Figure 40 Bio-Rad Laboratories, Inc.: Key Financials

Figure 41 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 42 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 43 Miltenyi Biotech: Key Financials

Figure 44 Miltenyi Biotech: Segmental Revenue

Figure 45 Miltenyi Biotech: Geographical Revenue

Figure 46 Nexcelom Bioscience LLC.: Key Financials

Figure 47 Nexcelom Bioscience LLC.: Segmental Revenue

Figure 48 Nexcelom Bioscience LLC.: Geographical Revenue